GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic inflammation, treated with first-in-class biologic Nucala® (mepolizumab) added-on to standard of care, achieved clinically and statistically significant improvements in their health-related quality of
Related Posts
The impact on quality of life on families of children on an elimination diet for Non-immunoglobulin E mediated gastrointestinal food allergies
The impact on health related quality of life (HRQL) has been well studied in children with Immunoglobulin E (IgE)-mediated food allergy. However limited data exists on related quality of life (QOL) of families… … lesen Sie weiter! Quelle: : http://waojournal.biomedcentral.com/articles/10.1186/s40413-016-0139-7
Lyck & Pätzold Medizinanwälte unterstützten zukünftig die Initiative gesundheitswirtschaft rhein-main e.V.
Auf Initiative des Referates Gesundheitswirtschaft im Bundesministerium für Wirtschaft ist der Gesundheitswirtschaft Rhein-Main e.V. 2006 gegründet worden und umfasst heute über 170 Mitglieder. Der Verein hat sich die Förderung und die Weiterentwicklung der Gesundheitswirtschaft in der Rhein-Main Region zum Ziel gesetzt. … Weiterlesen →
The Village Bakery Markethill recalls various own-branded bakery products
The Village Bakery Markethill is recalling numerous bakery products because they contain various undeclared or incorrectly labelled allergens. This means the products are a possible health risk for anyone with coeliac disease an allergy to wheat (glute…